Source link : https://www.newshealth.biz/health-news/many-european-cancer-drugs-offer-no-added-benefit/
Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, according to a new study from Utrecht University in the Netherlands. Researchers reported that “a large proportion” of new drug approvals offered minimal or no added benefit, and that this particularly applied to those approved through […]
Author : News Health
Publish date : 2024-02-29 14:19:23
Copyright for syndicated content belongs to the linked Source.
Categories